John L. Lamattina, Director of Ligand Pharmaceuticals LGND, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $2.4M. The latest trade was on 06/10.

JL

JL

John L. Lamattina

Director

Company

Ligand Pharmaceuticals LGND

First filing

23/01/17

Trades

26 trades

Buys / sales

0 / 8

12-month net buying

−$2.4M

Last trade

06/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ligand PharmaceuticalsLGND	Open-market sale	06/10	06/12	4,591 sh4 trades	$250.88avg.	$1,151,785.57	−14.5%
Ligand PharmaceuticalsLGND	Open-market sale	03/06	03/31	2,161 sh	$200.76	$433,842.36	−6.6%
Ligand PharmaceuticalsLGND	Open-market sale	25/11/07	25/11/12	4,179 sh2 trades	$205.45avg.	$858,575.55	−12.0%
Ligand PharmaceuticalsLGND	Open-market sale	24/11/27	24/12/02	2,406 sh	$123.65	$297,501.9	−7.5%